<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR3">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Durie</surname>
    <given-names>BG</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial</article-title>
  <source>Lancet</source>
  <year>2017</year>
  <volume>389</volume>
  <fpage>519</fpage>
  <lpage>527</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(16)31594-X</pub-id>
  <?supplied-pmid 28017406?>
  <pub-id pub-id-type="pmid">28017406</pub-id>
 </element-citation>
</ref>
